Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Is a |
Hydrofluoric acid burn antidote |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Calcium gluconate (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with chelating agent mechanism of action (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antidote |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrofluoric acid burn antidote (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
Gel (basic dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Is a |
Product containing calcium gluconate (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
Conventional release cutaneous gel (dose form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Is a |
Product manufactured as cutaneous dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
Calcium gluconate (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
Calcium gluconate (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has concentration strength numerator value |
25 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Is a |
Product containing only calcium gluconate in cutaneous dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|